Senile systemic amyloidosis

	Amyloidosis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification • Primary amyloidosis • Secondary amyloidosis • Familial amyloidosis • Wild-type (senile) amyloidosis • Cardiac amyloidosis • Beta-2 microglobulin related amyloidosis • Gelsolin related amyloidosis • Lysozyme amyloid related amyloidosis • Leucocyte cell-derived chemotaxin 2 related amyloidosis • Fibrinogen A alpha-chain associated amyloidosis
Pathophysiology
Causes
Differentiating Amyloidosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Senile systemic amyloidosis On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Senile systemic amyloidosis All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Senile systemic amyloidosis
CDC on Senile systemic amyloidosis
Senile systemic amyloidosis in the news
Blogs on Senile systemic amyloidosis
Directions to Hospitals Treating Psoriasis
Risk calculators and risk factors for Senile systemic amyloidosis

	WikiDoc Resources for Senile systemic amyloidosis
Articles
Most recent articles on Senile systemic amyloidosis Most cited articles on Senile systemic amyloidosis Review articles on Senile systemic amyloidosis Articles on Senile systemic amyloidosis in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Senile systemic amyloidosis Images of Senile systemic amyloidosis Photos of Senile systemic amyloidosis Podcasts & MP3s on Senile systemic amyloidosis Videos on Senile systemic amyloidosis
Evidence Based Medicine
Cochrane Collaboration on Senile systemic amyloidosis Bandolier on Senile systemic amyloidosis TRIP on Senile systemic amyloidosis
Clinical Trials
Ongoing Trials on Senile systemic amyloidosis at Clinical Trials.gov Trial results on Senile systemic amyloidosis Clinical Trials on Senile systemic amyloidosis at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Senile systemic amyloidosis NICE Guidance on Senile systemic amyloidosis NHS PRODIGY Guidance FDA on Senile systemic amyloidosis CDC on Senile systemic amyloidosis
Books
Books on Senile systemic amyloidosis
News
Senile systemic amyloidosis in the news Be alerted to news on Senile systemic amyloidosis News trends on Senile systemic amyloidosis
Commentary
Blogs on Senile systemic amyloidosis
Definitions
Definitions of Senile systemic amyloidosis
Patient Resources / Community
Patient resources on Senile systemic amyloidosis Discussion groups on Senile systemic amyloidosis Patient Handouts on Senile systemic amyloidosis Directions to Hospitals Treating Senile systemic amyloidosis Risk calculators and risk factors for Senile systemic amyloidosis
Healthcare Provider Resources
Symptoms of Senile systemic amyloidosis Causes & Risk Factors for Senile systemic amyloidosis Diagnostic studies for Senile systemic amyloidosis Treatment of Senile systemic amyloidosis
Continuing Medical Education (CME)
CME Programs on Senile systemic amyloidosis
International
Senile systemic amyloidosis en Espanol Senile systemic amyloidosis en Francais
Business
Senile systemic amyloidosis in the Marketplace Patents on Senile systemic amyloidosis
Experimental / Informatics
List of terms related to Senile systemic amyloidosis

	Senile systemic amyloidosis;
ICD-9	277.3
OMIM	176300
eMedicine	med/3365

Senile systemic amyloidosis is a form of amyloidosis associated with transthyretin.^[1]

It is estimated to affect a quarter of the population over 85 years of age.^[2]

References

↑ Westermark P, Sletten K, Johansson B, Cornwell GG (1990). "Fibril in senile systemic amyloidosis is derived from normal transthyretin". Proc. Natl. Acad. Sci. U.S.A. 87 (7): 2843–5. PMC 53787. PMID 2320592. Unknown parameter |month= ignored (help)
↑ Tanskanen M, Peuralinna T, Polvikoski T; et al. (2008). "Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in alpha2-macroglobulin and tau: a population-based autopsy study". Ann. Med. 40 (3): 232–9. doi:10.1080/07853890701842988. PMID 18382889. Text "1B69BA326FFE69C3F0A8F227DF8201D0" ignored (help)

Template:Nephrology

Template:WikiDoc Sources

[pmid2320592-1] Westermark P, Sletten K, Johansson B, Cornwell GG (1990). "Fibril in senile systemic amyloidosis is derived from normal transthyretin". Proc. Natl. Acad. Sci. U.S.A. 87 (7): 2843–5. PMC 53787. PMID 2320592. Unknown parameter |month= ignored (help)

[pmid18382889-2] Tanskanen M, Peuralinna T, Polvikoski T; et al. (2008). "Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in alpha2-macroglobulin and tau: a population-based autopsy study". Ann. Med. 40 (3): 232–9. doi:10.1080/07853890701842988. PMID 18382889. Text "1B69BA326FFE69C3F0A8F227DF8201D0" ignored (help)

[1]

[2]

Senile systemic amyloidosis
ICD-9	277.3
OMIM	176300
eMedicine	med/3365

Senile systemic amyloidosis

References

Navigation menu

Search